FranΓ§aisπ See the interactive version (live chart) β
| Investment | Value today | Gain |
|---|---|---|
| 1 years ago (2025) | $961 | -4% |
| 3 years ago (2023) | $954 | -5% |
| 5 years ago (2021) | $632 | -37% |
| 10 years ago (2016) | $2,326 | +133% |
| since 1991 | $12,000 | +1100% |
| Year | Year's return | $1,000 invested at year start β worth today |
|---|---|---|
| 2026 (YTD) | -6% | $936 (-6%) |
| 2025 | +3% | $961 (-4%) |
| 2024 | -9% | $877 (-12%) |
| 2023 | +9% | $954 (-5%) |
| 2022 | +48% | $1,414 (+41%) |
| 2021 | -55% | $632 (-37%) |
| 2020 | +3% | $653 (-35%) |
| 2019 | +15% | $750 (-25%) |
| 2018 | +72% | $1,291 (+29%) |
| 2017 | +44% | $1,866 (+87%) |
| 2016 | +25% | $2,326 (+133%) |
π See the analyst analysis of Haemonetics β
$1000 invested in Haemonetics 5 years ago would be worth $632 today, and $2,326 over 10 years (price return, excluding dividends).
Calendar-year returns β 2024: -9%. 2025: +3%. 2026: -6%. Full breakdown in the table above.
Over 10 years, Haemonetics's average annual return (CAGR) is about 9% per year, and -9%/yr over 5 years.
Best year: 2018 (+72%). Worst year: 2021 (-55%).
It's proportional β just multiply. Over 5 years, $1,000 invested in Haemonetics is worth $632, so $100 would be worth a tenth, $5,000 five times more, and $10,000 ten times more. Use the calculator at the top of the page for your exact amount and chosen year.
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Past performance, no predictive value and not investment advice. Prices in $, excluding dividends. Data: Yahoo Finance.